Drugs for Urinary Frequency and Incontinence

Name
Drugs for Urinary Frequency and Incontinence
Accession Number
DBCAT002216
Description

Not Available

ATC Classification
Drugs
DrugDrug Description
TrospiumAn antimuscarinic agent used to treat the symptoms of overactive bladder (OAB).
DarifenacinAn M3 muscarinic receptor blocker used to treat urinary incontinence.
TolterodineA muscarinic receptor antagonist used to treat overactive bladder with urinary incontinence, urgency, and frequency.
OxybutyninAn antimuscarinic agent that reduces detrusor muscle activity, relaxing the bladder and preventing the urge to void.
FlavoxateA muscarinic antagonist and spasmolytic used for the symptomatic relief of conditions associated with lack of muscle control in the bladder, such as dysuria, urgency, and nocturia.
FesoterodineAn antimuscarinic agent used in the treatment of overactive bladder with symptoms of urge urinary incontinence, urgency, and frequency.
MirabegronA beta-3 adrenergic agonist used to treat overactive bladder and neurogenic detrusor overactivity.
PropiverineAn antimuscarinic agent used to treat urinary incontinence or increased urinary frequency or urgency.
MeladrazineNot Annotated
EmeproniumNot Annotated
TerodilineNot Annotated
SolifenacinA muscarinic antagonist with antispasmodic properties used to treat urge urinary incontinence, urgency, and urinary frequency associated with an overactive bladder.
DesfesoterodineAn antimuscarinic agent indicated in the symptomatic treatment of urinary frequency or incontinence.
VibegronA beta-3 adrenergic agonist the treatment of overactive bladder (OAB) with symptoms of urge urinary incontinence, urgency, and urinary frequency in adults.
SolabegronInvestigated for use/treatment in diabetes mellitus type 2, irritable bowel syndrome (IBS), and urinary incontinence.
RitobegronRitobegron is under investigation in clinical trial NCT02256735 (Study to Investigate the Effect of KUC 7483 CL on the QT/QTc Interval of the ECG in Comparison to Placebo and Moxifloxacin...
ImidafenacinAn antispasmodic with anticholinergic effects used to reduce urinary frequency.
Drugs & Drug Targets
DrugTargetType
TrospiumMuscarinic acetylcholine receptor M1target
TrospiumCytochrome P450 2D6enzyme
TrospiumMuscarinic acetylcholine receptor M3target
DarifenacinMuscarinic acetylcholine receptor M3target
DarifenacinCytochrome P450 3A4enzyme
DarifenacinCytochrome P450 2D6enzyme
DarifenacinMuscarinic acetylcholine receptor M1target
DarifenacinMuscarinic acetylcholine receptor M2target
DarifenacinMuscarinic acetylcholine receptor M4target
DarifenacinMuscarinic acetylcholine receptor M5target
TolterodineMuscarinic acetylcholine receptor M1target
TolterodineMuscarinic acetylcholine receptor M2target
TolterodineMuscarinic acetylcholine receptor M3target
TolterodineCytochrome P450 2D6enzyme
TolterodineCytochrome P450 3A4enzyme
TolterodineCytochrome P450 2C9enzyme
TolterodineCytochrome P450 2C19enzyme
TolterodineMuscarinic acetylcholine receptor M4target
TolterodineMuscarinic acetylcholine receptor M5target
OxybutyninMuscarinic acetylcholine receptor M1target
OxybutyninMuscarinic acetylcholine receptor M2target
OxybutyninMuscarinic acetylcholine receptor M3target
OxybutyninCytochrome P450 3A4enzyme
OxybutyninCytochrome P450 2C8enzyme
OxybutyninCytochrome P450 2D6enzyme
OxybutyninCytochrome P450 3A5enzyme
OxybutyninAlpha-1-acid glycoprotein 1carrier
OxybutyninSerum albumincarrier
FlavoxateMuscarinic acetylcholine receptor M1target
FlavoxateMuscarinic acetylcholine receptor M2target
FesoterodineMuscarinic acetylcholine receptor M1target
FesoterodineMuscarinic acetylcholine receptor M3target
FesoterodineCytochrome P450 3A4enzyme
FesoterodineMuscarinic acetylcholine receptor M2target
FesoterodineMuscarinic acetylcholine receptor M4target
FesoterodineMuscarinic acetylcholine receptor M5target
FesoterodineCytochrome P450 2D6enzyme
FesoterodineP-glycoprotein 1transporter
MirabegronCytochrome P450 3A4enzyme
MirabegronCytochrome P450 2D6enzyme
MirabegronP-glycoprotein 1transporter
MirabegronSolute carrier organic anion transporter family member 1A2transporter
MirabegronSerum albumincarrier
MirabegronAlpha-1-acid glycoprotein 1carrier
MirabegronCholinesteraseenzyme
MirabegronBeta-3 adrenergic receptortarget
MirabegronUDP-glucuronosyltransferase 2B7enzyme
MirabegronUDP-glucuronosyltransferase 1-3enzyme
MirabegronUDP-glucuronosyltransferase 1-8enzyme
MirabegronSolute carrier family 22 member 1transporter
MirabegronSolute carrier family 22 member 2transporter
MirabegronSolute carrier family 22 member 3transporter
MirabegronBeta-1 adrenergic receptortarget
PropiverineMuscarinic acetylcholine receptor M1target
PropiverineMuscarinic acetylcholine receptor M2target
PropiverineMuscarinic acetylcholine receptor M3target
PropiverineMuscarinic acetylcholine receptor M4target
PropiverineMuscarinic acetylcholine receptor M5target
PropiverineVoltage-dependent L-type calcium channel subunit alpha-1Ctarget
PropiverineAlpha-1A adrenergic receptortarget
PropiverineCytochrome P450 3A4enzyme
PropiverineDimethylaniline monooxygenase [N-oxide-forming] 1enzyme
PropiverineDimethylaniline monooxygenase [N-oxide-forming] 3enzyme
TerodilineCytochrome P450 3A4enzyme
SolifenacinMuscarinic acetylcholine receptor M3target
SolifenacinMuscarinic acetylcholine receptor M1target
SolifenacinCytochrome P450 3A4enzyme
SolifenacinMuscarinic acetylcholine receptor M2target
SolifenacinMuscarinic acetylcholine receptor M4target
SolifenacinMuscarinic acetylcholine receptor M5target
Solifenacinalpha1-acid glycoproteincarrier
SolifenacinCytochrome P450 1A1enzyme
SolifenacinCytochrome P450 2D6enzyme
VibegronBeta-3 adrenergic receptortarget
VibegronCytochrome P450 3A4enzyme
VibegronP-glycoprotein 1transporter
SolabegronBeta-3 adrenergic receptortarget
ImidafenacinMuscarinic acetylcholine receptor M1target
ImidafenacinMuscarinic acetylcholine receptor M2target
ImidafenacinMuscarinic acetylcholine receptor M3target
ImidafenacinCytochrome P450 3A4enzyme
ImidafenacinUDP-glucuronosyltransferase 1-4enzyme
ImidafenacinSerum albumincarrier
Imidafenacinalpha1-acid glycoproteincarrier